ALSO NOTED: ABC urged to cancel vaccine-related show; New studies on H5N1 vaccines; and much more...

Vaccine Market

The American Academy of Pediatrics wants ABC to cancel "Eli Stone," a new show, saying it gives its audience the false idea that vaccines cause autism. In the first episode, a mother wins $5.2 million on the claim that her son contracted autism from a vaccine. Report

With the CDC recommending 16 different vaccines for children now, parents are being called on to better organize their kids' vaccine schedules. About one in four children under three don't get the full schedule of recommended vaccines. Report

The European Medicines Agency says it has no plans to change the labels on Merck's Gardasil after two women who had received the cervical cancer vaccine died. Report

A variety of news reports point to a spike in flu cases around the U.S. Report

A doctor discusses patient attitudes about the new shingles vaccine; some are easy to convince. Article

New Zealand has approved the cervical cancer vaccine Cervarix. Report

Vaccine Research

A vaccine against the most common and deadliest strain of avian flu, H5N1, has been engineered and tested by researchers at the University of Pittsburgh's Center for Vaccine Research and Novavax. The vaccine produced a strong immune response in mice and protected them from death following infection with the H5N1 virus. The vaccine is being tested in humans in an early-phase clinical trial. Release

Kaiser Permanente has recruited members to test a genetically engineered flu vaccine--FluBlok--that could be used in the event of a pandemic. Release

The experimental malaria vaccine MSP3-LSP is being tested in Tanzania. Report

Arizona State scientists have won a $1.5 million grant to determine if tobacco can produce a vaccine for West Nile virus. Report 

Suggested Articles

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.

Ebola has claimed thousands of lives in recent outbreaks, but now the world has a licensed vaccine option in Merck's Ervebo.

Cosette Pharmaceuticals which was formed in December with a deal for dermatology projects has gone back to G&W Labs for a liquids plant.